Literature DB >> 24836856

Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.

R C Bates1, B J Stith2, K E Stevens3, C E Adams4.   

Abstract

Decreased expression of CHRNA7, the gene encoding the α7(∗) subtype of nicotinic receptor, may contribute to the cognitive dysfunction observed in schizophrenia by disrupting the inhibitory/excitatory balance in the hippocampus. C3H mice with reduced Chrna7 expression have significant reductions in hippocampal α7(∗) receptor density, deficits in hippocampal auditory gating, increased hippocampal activity as well as significant decreases in hippocampal glutamate decarboxylase-65 (GAD65) and γ-aminobutyric acid-A (GABAA) receptor levels. The current study investigated whether altered Chrna7 expression is associated with changes in the levels of parvalbumin, GAD67 and/or GABAA receptor subunits in the hippocampus from male and female C3H Chrna7 wildtype, C3H Chrna7 heterozygous and C3H Chrna7 knockout (KO) mice using quantitative Western immunoblotting. Reduced Chrna7 expression was associated with significant increases in hippocampal parvalbumin and GAD67 and with complex alterations in GABAA receptor subunits. A decrease in α3 subunit protein was seen in both female C3H Chrna7 Het and KO mice while a decrease in α4 subunit protein was also detected in C3H Chrna7 KO mice with no sex difference. In contrast, an increase in δ subunit protein was observed in C3H Chrna7 Het mice while a decrease in this subunit was observed in C3H Chrna7 KO mice, with δ subunit protein levels being greater in males than in females. Finally, an increase in γ2 subunit protein was found in C3H Chrna7 KO mice with the levels of this subunit again being greater in males than in females. The increases in hippocampal parvalbumin and GAD67 observed in C3H Chrna7 mice are contrary to reports of reductions in these proteins in the postmortem hippocampus from schizophrenic individuals. We hypothesize that the disparate results may occur because of the influence of factors other than CHRNA7 that have been found to be abnormal in schizophrenia.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chrna7; GABA(A) receptors; glutamate decarboxylase 67 (GAD67); parvalbumin; schizophrenia; λ-aminobutyric acid (GABA)

Mesh:

Substances:

Year:  2014        PMID: 24836856      PMCID: PMC4122271          DOI: 10.1016/j.neuroscience.2014.05.004

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  82 in total

Review 1.  NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2012-02-21       Impact factor: 9.306

2.  Distinct neural generators of sensory gating in schizophrenia.

Authors:  Terrance J Williams; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Psychophysiology       Date:  2010-08-23       Impact factor: 4.016

Review 3.  GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

Authors:  Bernhard Luscher; Thomas Fuchs; Casey L Kilpatrick
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 4.  Dynamic neural systems enable adaptive, flexible memories.

Authors:  Marijn C W Kroes; Guillén Fernández
Journal:  Neurosci Biobehav Rev       Date:  2012-02-28       Impact factor: 8.989

Review 5.  Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.

Authors:  Tanya L Wallace; Richard H P Porter
Journal:  Biochem Pharmacol       Date:  2011-07-02       Impact factor: 5.858

6.  Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia.

Authors:  Jason R Tregellas; Deana B Davalos; Donald C Rojas; Merilyne C Waldo; Linzi Gibson; Korey Wylie; Yiping P Du; Robert Freedman
Journal:  Schizophr Res       Date:  2007-03-02       Impact factor: 4.939

7.  Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.

Authors:  C Procaccini; M Maksimovic; T Aitta-Aho; E R Korpi; A-M Linden
Journal:  Neuroscience       Date:  2013-07-15       Impact factor: 3.590

8.  Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain.

Authors:  M S Todtenkopf; F M Benes
Journal:  Synapse       Date:  1998-08       Impact factor: 2.562

9.  Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia.

Authors:  Carlotta E Duncan; Maree J Webster; Debora A Rothmond; Sabine Bahn; Michael Elashoff; Cynthia Shannon Weickert
Journal:  J Psychiatr Res       Date:  2010-01-25       Impact factor: 4.791

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  4 in total

1.  The α7 nicotinic acetylcholine receptors regulate hippocampal adult-neurogenesis in a sexually dimorphic fashion.

Authors:  Simone L Otto; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2018-12-04       Impact factor: 3.270

Review 2.  Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis.

Authors:  Andrew M Rosen; Timothy Spellman; Joshua A Gordon
Journal:  Biol Psychiatry       Date:  2015-03-27       Impact factor: 13.382

Review 3.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

4.  Loss of α7 nicotinic acetylcholine receptors in GABAergic neurons causes sex-dependent decreases in radial glia-like cell quantity and impairments in cognitive and social behavior.

Authors:  Samir A Nacer; Ayland C Letsinger; Simone Otto; Jemma Strauss DeFilipp; Viktoriya D Nikolova; Natallia V Riddick; Korey D Stevanovic; Jesse D Cushman; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2021-01-04       Impact factor: 3.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.